Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Vaccine. 2020 Mar 17;38(18):3411–3421. doi: 10.1016/j.vaccine.2020.03.014

Fig. 3.

Fig. 3

Flow of participants. The RTS,S coad group received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age and the YF and MR vaccines at 9 months of age; the RTS,S alone group received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age; and the Control group received the YF and MR vaccines at 9 months of age. N, number of children, M, month; RTS,S/AS01, pre-erythrocytic Plasmodium falciparum malaria vaccine; YF, yellow fever; MR, combined measles-rubella. *An informed consent form was signed for 9 children when the enrolment target was met and these children were not included in the study.